# Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis

> **NCT01554124** · PHASE1,PHASE2 · COMPLETED · sponsor: **PENTA Foundation** · enrollment: 51 (actual)

## Conditions studied

- Meningitis

## Interventions

- **DRUG:** Meropenem

## Key facts

- **NCT ID:** NCT01554124
- **Lead sponsor:** PENTA Foundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2015-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01554124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01554124, "Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01554124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*